Trending
Revolutionary Shows Promise 4
Revolutionary Shows Promise 3
Revolutionary Shows Promise 1
Revolutionary aids Treatment Shows Promise
Revolutionary Cancer Treatment Shows Promise
FDA Expands Approval of Vonvendi for von Willebrand Disease, Including Pediatric Use
Child Depression Fluctuations may trigger Parent Depression not vice versa: JAMA
Indoor Air Quality and Diet Found to Regulate Inflammation in Childhood: Study Finds
How Smoking Fuels Pancreatic Cancer Growth and Worsens Outcomes: Study Finds Out
Follow Us:
November 03, 2025

Get In Touch

GSK pulmonary neuroendocrine carcinoma treatment gets Orphan Drug Designation in EU Oncology

GSK pulmonary neuroendocrine carcinoma treatment gets Orphan Drug Designation in EU

  • 31 October 2025
  • 2 days ago

Dr Reddy's Labs receives positive EMA Committee opinion for proposed biosimilar of Prolia, Xgeva Obstetrics and Gynaecology

Dr Reddy's Labs receives positive EMA Committee opinion for proposed biosimilar of Prolia, Xgeva

  • 23 September 2025
  • 1 month ago

Roche subcutaneous formulation of Lunsumio recommended by CHMP for EU nod for follicular lymphoma Pharma News

Roche subcutaneous formulation of Lunsumio recommended by CHMP for EU nod for follicular lymphoma

  • 21 September 2025
  • 1 month ago

Merck receives positive EU CHMP opinion for Enflonsia for RSV in infants Pharma News

Merck receives positive EU CHMP opinion for Enflonsia for RSV in infants

  • 21 September 2025
  • 1 month ago

JnJ gets positive CHMP opinion of nipocalimab for antibody-positive patients living with generalised myasthenia gravis Pharma News

JnJ gets positive CHMP opinion of nipocalimab for antibody-positive patients living with generalised myasthenia gravis

  • 21 September 2025
  • 1 month ago

Bayer Elinzanetant recommended for nod in EU for moderate to severe vasomotor symptoms Pharma News

Bayer Elinzanetant recommended for nod in EU for moderate to severe vasomotor symptoms

  • 20 September 2025
  • 1 month ago

EMA Committee approves update to Novo Nordisk Rybelsus label to reflect cardiovascular benefits Pharma News

EMA Committee approves update to Novo Nordisk Rybelsus label to reflect cardiovascular benefits

  • 18 September 2025
  • 1 month ago

EMA Recommends Expanded Use Of Remdesivir On Compassionate Grounds Medicine

EMA Recommends Expanded Use Of Remdesivir On Compassionate Grounds

  • 20 July 2025
  • 3 months ago

Recent News

GLP-1 Receptor Agonists Linked to Lower Risk of Ea...

  • 03 November, 2025

Ketogenic diet may protect against stress experien...

  • 03 November, 2025

STORM-PE Trial: Mechanical Thrombectomy Shows Supe...

  • 03 November, 2025

AIIMS INI CET January 2026 admit cards released

  • 03 November, 2025

Daily Newsletter

Get all the top stories from Blogs to keep track.